Apostle
Apostle Inc develops proprietary magnetic nanoparticle-based nucleic acid isolation kits and automated extraction instruments (MagTouch 2000) for liquid biopsy applications, serving academic research institutions, clinical diagnostic labs, OEM partners, and public health agencies across global markets.
- Company typePrivate
- Founded2017
- HeadquartersPleasanton, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Apostle does
Apostle Inc is a privately held biotechnology company founded in 2017 and headquartered in Pleasanton, California, that develops and commercializes proprietary magnetic nanoparticle-based nucleic acid isolation and preservation technologies for liquid biopsy and molecular diagnostics applications. The company's core technology platform, branded as MiniMax, includes cfDNA and cfRNA isolation kits that deliver approximately 40% higher cell-free DNA yield than incumbent Qiagen QIAamp kits, with phenol- and chloroform-free formulations. Apostle's product portfolio spans the MiniMax reagent family (cfDNA, cfRNA, combined cfNAs kits), the MagTouch 2000 automated extraction instrument in 24-well and 96-well formats (priced at $35,000 per unit), MiniEnrich size-selection and purification beads, MiniGenomics stool DNA isolation kits, cfDNA blood collection tubes (BCT), and the RiboCraft transfection reagent. The company has processed more than 20 million samples since founding and its technologies are cited in over 50 peer-reviewed publications including Nature Medicine, Cancer Cell, and Science Translational Medicine.
Apostle generates revenue through four streams: direct e-commerce sales of reagent kits and consumables (priced $16-$680 per kit), capital instrument sales of the MagTouch 2000, OEM and private-label supply to diagnostic companies including SneakPeek Test and BGI Genomics (including CE-marked kits for European markets), and laboratory services including cfDNA/cfRNA isolation and clinical CRO work. The company employs 51-100 staff and pursues a dual go-to-market combining self-service e-commerce for individual researchers with enterprise field sales to academic medical centers, government research institutions, and commercial diagnostic labs. Distribution of Haier Biomedical laboratory equipment (ULT freezers, CO2 incubators, biological safety cabinets) to leading institutions including Stanford, UCSF, and Washington University in St. Louis provides an additional channel revenue layer. Validated integrations with KingFisher Flex, Beckman Coulter Biomek, and Bio-Rad QX ONE ddPCR systems embed Apostle reagents into established laboratory automation ecosystems.
The company is owned by founders and management without disclosed institutional venture backing beyond a $5.68 million combined seed and Series A raise in 2017 and 2019; no subsequent funding rounds appear in the source data. Key leadership includes CEO David Ge, Co-founder and VP Bioinformatics Xin Guo, Co-founder and SVP Medicine Wenqi Zeng, Chairman Hongyu Zhao (Yale Biostatistics), and VP of Business Operations Eric Masingale. Named end-customers span NIH, MD Anderson Cancer Center, Memorial Sloan Kettering, Mayo Clinic, Stanford, UCSF, Columbia, Duke, Yale, and SpaceX/Axiom Space, with notable flagship partnerships including Beckman Coulter Life Sciences for co-validation and the Axiom-2 commercial space mission for astronaut bio-specimen collection.
Apostle firmographics
Firmographics- Name
- Apostle
- Legal name
- Apostle Inc
- Website
- https://apostlebio.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Apostle Inc develops proprietary magnetic nanoparticle-based nucleic acid isolation kits and automated extraction instruments (MagTouch 2000) for liquid biopsy applications, serving academic research institutions, clinical diagnostic labs, OEM partners, and public health agencies across global markets.
- Ownership category
- akta.pro rank
Apostle industry classification
Industry- Product category
- Molecular Diagnostics Reagents & Instruments
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Metrology, Calibration & Testing Equipment (Balances, pH/DO, Standards) (HLAGAIAL)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Apostle is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Apostle business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Reagent Kits and Consumables: Sale of nucleic acid isolation kits (cfDNA, cfRNA, genomic DNA), kit components, magnetic nanoparticles, and laboratory consumables. Products sold in various sizes (e.g., 50 preps, 384 preps) through direct e-commerce.
- Lab Instruments: Sale of automated nucleic acid extraction systems (MagTouch 2000), Haier Biomedical freezers and lab equipment. Instruments like MagTouch 2000 priced at $35,000.
- Laboratory Services: cfDNA/cfRNA isolation services, clinical laboratory services, and CRO lab services offered to customers who prefer outsourcing.
- OEM/Private Label: Apostle acts as OEM supplier for other diagnostic companies including SneakPeek Test (gender prediction test) and BGI Genomics (stool DNA isolation kit CE marked products).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | MagTouch 2000 Nucleic Acid Extraction Automation System |
| Unit Pricing | Pay-as-you-go | MiniMax High Efficiency cfDNA Isolation Kit |
| Unit Pricing | Pay-as-you-go | MiniMax cfDNA Blood Collection Tubes |
| Unit Pricing | Pay-as-you-go | MiniGenomics Stool DNA Isolation Kit |
| Unit Pricing | Pay-as-you-go | Lab Consumables (Pipettes, Plates, Tubes) |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Apostle product offering
Product offeringCore offering
Apostle develops and sells proprietary magnetic nanoparticle-based nucleic acid isolation kits and instruments for liquid biopsy and molecular diagnostics applications. Its core MiniMax product line isolates cell-free DNA and cell-free RNA from plasma and other samples with higher yield than leading competitors, complemented by the MagTouch 2000 automated extraction platform, blood collection tubes, size-selection beads, and a broad catalog of lab consumables and distributed Haier Biomedical equipment. The company also offers CRO and cfDNA/cfRNA isolation laboratory services and acts as an OEM supplier for diagnostic test developers.
Product overview
Apostle is a biotechnology company developing and providing nucleic acid isolation and preservation technologies primarily for liquid biopsy applications. The product portfolio centers on the proprietary MiniMax technology platform (comprising cfDNA, cfRNA, and combined isolation kits), supplemented by MiniEnrich (DNA size selection and purification beads), MiniGenomics (genomic DNA isolation including stool DNA), and MagTouch (automated extraction instruments in 24-well and 96-well formats). Key add-on products include blood collection tubes, viral/pathogen isolation kits, and transfection reagents. The company also distributes Haier Biomedical laboratory equipment and offers a comprehensive line of lab consumables (900+ SKUs). Services include cfDNA/cfRNA isolation services and clinical laboratory/CRO services. The technology is validated in over 100 publications including high-impact journals (Nature Medicine, Cancer Cell, Science Translational Medicine) and was featured in Science journal (2019) as a new product. Notable applications include cancer detection, non-invasive prenatal testing (NIPT), infectious disease surveillance, and space mission bio-specimen processing.
Differentiator
Problem solved
Functional benefit
Brands
- MiniMax: High-efficiency cell-free DNA/RNA isolation technology platform for liquid biopsy applications
- MagTouch
- MiniEnrich
- MiniGenomics
- BCT
- Triton
- CheckMeSafe
- RiboCraft
Products and services
- Apostle MiniMax High Efficiency cfDNA Isolation Kit Magnetic nanoparticle-based cell-free DNA isolation kit delivering best-in-class yield and purity from plasma and other biological samples, powering liquid biopsy applications including cancer detection, NIPT, and disease surveillance.
- Apostle MiniMax High Efficiency cfRNA Isolation Kit High-efficiency cell-free RNA isolation kit enabling early cancer detection and classification across multiple cancer types through cfRNA analysis from liquid biopsy samples without phenol or chloroform.
- Apostle MiniMax cfDNA/cfRNA (cfNAs) Isolation Kit Combined isolation kit for simultaneous extraction of both cell-free DNA and RNA from a single sample, enabling comprehensive liquid biopsy analysis for hematologic and solid tumors.
- Apostle MagTouch 2000 Nucleic Acid Extraction Automation System (24-well) Automated magnetic bead-based nucleic acid extraction instrument processing 24 samples per run with one-button operation; used extensively for COVID-19 testing with over 20 million samples processed during the pandemic.
- Apostle MagTouch 2000 Nucleic Acid Extraction Automation System (96-well) High-throughput automated nucleic acid extraction system processing 96 samples per run using magnetic bead technology for various biological sample types; priced at $35,000 per unit.
- Apostle MiniMax Cell-Free DNA Blood Collection Tube (BCT) Specialized blood collection tube for cfDNA preservation during blood collection, storage and transport, preventing genomic DNA contamination and preserving existing cfDNA from degradation.
- Apostle MiniGenomics Stool DNA Isolation Kit Magnetic nanoparticle-based kit for rapid extraction of high-quality genomic DNA from fresh or frozen stool samples, enabling colorectal cancer screening through DNA methylation biomarker analysis.
- RiboCraft Alpha Transfection Reagent Dual-function transfection reagent developed from Stanford University research, capable of both in vitro and in vivo RNA delivery including mRNA, siRNA, and gene-editing tools.
- Apostle Viral/Pathogen NA Isolation Kits Viral and pathogen nucleic acid isolation reagents including the Virus Total NA Isolation Fast Kit used for SARS-CoV-2 wastewater surveillance by Nevada State Public Health Laboratory.
- Apostle Lab Consumables Catalog Comprehensive 900+ SKU line of laboratory consumables including cell culture dishes, flasks, plates, serological pipettes, pipette tips, centrifuge tubes, and microcentrifuge tubes offered at 30%+ cost savings versus competitors.
- Haier Biomedical Lab Freezers and Equipment (Distributed by Apostle) Distribution of Haier Biomedical laboratory equipment including -86°C ULT Freezers, Biomedical Freezers, Pharmacy Refrigerators, CO₂ Incubators, Biological Safety Cabinets, and Liquid Nitrogen Storage systems to research institutions including Stanford, UCSF, and Washington University in St. Louis.
- Apostle cfDNA/cfRNA Isolation Services Laboratory services providing cell-free DNA and RNA isolation for research and clinical applications using Apostle's proprietary MiniMax technology for customers that prefer outsourced sample processing.
- Apostle Clinical Laboratory & CRO Services Contract research organization laboratory services and clinical laboratory testing services for pharmaceutical and biotechnology clients needing outsourced nucleic acid isolation and downstream analysis.
Quantifiable outcome
- 40% average improvement in cfDNA isolation yield vs Qiagen QIAamp (Beckman Coulter Technical Note 2022)
- +5 more outcomes
Companies that use Apostle
Customer profileNamed customers20 records
Segments4 records
Ideal customer profiles4 records
Apostle technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability2 records
Feature7 records
Apostle partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, notable and flagship.
- Beckman Coulter Life SciencescoreCollaborative partnership for technology validation and co-marketing. Beckman Coulter scientists published multiple technical notes and data sheets comparing Apostle MiniMax technology against competitors. Products are distributed through Beckman Coulter channels and featured in FDA documents.
- Haier BiomedicalcoreApostle is a major distributor of Haier Biomedical products including -86°C ULT freezers, biomedical freezers, pharmacy refrigerators, biological safety cabinets, and CO2 incubators. Products distributed to leading research institutions including Stanford, UCSF, and Washington University in St. Louis.
- BGI GenomicsnotableApostle serves as OEM supplier for BGI Genomics' Stool Sample Collection Kit and DNA Isolation Kit for Methylation Detection, which received CE marking for European market. Apostle manufactures products under BGI brand.
- SneakPeek TestApostle is the Original Equipment Manufacturer supplier for SneakPeek gender prediction test kits, providing cfDNA isolation technology for non-invasive prenatal gender testing.
- Fulgent GeneticsnotableLab Director Dr. Harry Gao praised Apostle's COVID-19 RNA extraction system and MagTouch automation during pandemic. Fulgent used Apostle products for high-volume SARS-CoV-2 testing with reliable results.
- SpaceX / Axiom SpaceflagshipApostle MiniMax technology selected for astronaut bio-specimen collection on Axiom-2 commercial space mission (SpaceX Health Mission). Published in npj Microgravity (Nature Publishing Group). First official manual for astronaut specimen collection includes Apostle technology as standard protocol.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Apostle competitors and assessment
Company assessmentDirect peers
- Qiagen: Qiagen is the global leader in nucleic acid extraction kits (QIAamp, QIAsymphony) and is the explicit benchmark Apostle cites in its 40% yield improvement claim. Qiagen directly competes with Apostle MiniMax, MiniGenomics, and viral NA kits across virtually all of Apostle's target segments.
- Zymo Research: Zymo Research is a closely comparable private competitor offering cfDNA/cfRNA isolation kits, genomic DNA kits (including stool), and purification beads targeting the same liquid biopsy and molecular biology customers as Apostle. Like Apostle, it competes on yield and price while pursuing direct-to-lab e-commerce.
- Promega: Promega offers Maxwell and ReliaPrep automated nucleic acid extraction systems plus ReliaPrep cfDNA/cfRNA kits, directly overlapping with Apostle's MagTouch and MiniMax product lines. Both companies target clinical research labs with integrated reagent/instrument bundles.
- Norgen Biotek: Norgen Biotek is a smaller, privately-held Canadian competitor specializing in nucleic acid and cfDNA/cfRNA isolation kits from diverse sample types including stool, blood, and urine, closely mirroring Apostle's sample-type breadth and academic-customer base.
- Macherey-Nagel: Macherey-Nagel manufactures NucleoSpin and NucleoMag DNA/RNA isolation kits and magnetic-bead based kits that compete head-to-head with Apostle's MiniMax and MiniGenomics lines, particularly in European and academic research labs.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher sells competing sample-prep chemistries (MagMAX, Invitrogen PureLink), the KingFisher Flex automated extraction platform that Apostle's MiniMax kit is validated against, and bundles these with downstream qPCR/sequencing reagents. It is the dominant broad-line incumbent Apostle must displace in larger accounts.
- Bio-Rad Laboratories: Bio-Rad sells the QX ONE droplet digital PCR system (which Apostle's MiniMax is validated for use with) and other molecular biology consumables. It is a downstream-instrument incumbent whose installed base influences reagent purchasing decisions in the same labs Apostle targets.
Emerging players
- Covaris: Covaris provides automated sample-prep technologies (Adaptive Focused Acoustics) used upstream of cfDNA workflows for cell-free DNA and FFPE applications. It represents a different technical approach to the same sample-prep bottleneck Apostle addresses with magnetic nanoparticles.
Others
- Beckman Coulter Life Sciences: Beckman Coulter is both a strategic partner (publishing validation technical notes for Apostle kits and featuring them in FDA documents) and a competitor via AMPure XP purification beads (which Apostle's MiniEnrich directly displaces) and Biomek liquid handlers. The dual partner/competitor dynamic makes it the closest ecosystem peer.
- BGI Genomics: BGI is both an OEM partner (CE-marked stool DNA kits manufactured by Apostle) and a broader molecular diagnostics services provider. The relationship illustrates how Apostle's chemistry gets embedded into much larger global diagnostic platforms while exposing Apostle to channel-power dynamics.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Apostle social profiles
Digital presenceApostle compliance and trust
Trust signalCompliance4 records
Apostle financial estimates
Financial estimateRevenue estimate
Valuation estimate
Apostle leadership team
Management profileNumber of profiles
Profiles6 records
Apostle subsidiaries and ownership
Company hierarchySubsidiaries1 record
Apostle funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Apostle M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Apostle
What does Apostle do?
Apostle develops and sells proprietary magnetic nanoparticle-based nucleic acid isolation kits and instruments for liquid biopsy and molecular diagnostics applications. Its core MiniMax product line isolates cell-free DNA and cell-free RNA from plasma and other samples with higher yield than leading competitors, complemented by the MagTouch 2000 automated extraction platform, blood collection tubes, size-selection beads, and a broad catalog of lab consumables and distributed Haier Biomedical equipment. The company also offers CRO and cfDNA/cfRNA isolation laboratory services and acts as an OEM supplier for diagnostic test developers.
Is Apostle a public or private company?
Apostle is a private company. It is classified as venture growth investor backed and is currently operating.
When was Apostle founded?
Apostle was founded in 2017. It employs 51 to 100 people.
Where is Apostle based?
Apostle is headquartered in Pleasanton, United States, in the North America region.
How does Apostle make money?
Four revenue lines are on record. Reagent Kits and Consumables are the primary driver. The others are lab Instruments, laboratory Services and OEM/Private Label.
Who are Apostle's main competitors?
Direct peers on record are Qiagen, Zymo Research, Promega, Norgen Biotek and Macherey-Nagel. Broad incumbents are Thermo Fisher Scientific and Bio-Rad Laboratories. Covaris is listed as an emerging player. Others are Beckman Coulter Life Sciences and BGI Genomics.
Does Apostle have an API?
No public API is recorded for Apostle.
What industry is Apostle in?
Apostle's product category is Molecular Diagnostics Reagents & Instruments. Its primary akta.pro industry code is HLAGAIAL, Metrology, Calibration & Testing Equipment (Balances, pH/DO, Standards), with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 325413 and its SIC code is 2835.